Total Payments
$429.28
2024 Payments
$19.17
Companies
11
Transactions
24
Medicare Patients
984
Medicare Billing
$119,571
Payment Breakdown by Category
Food & Beverage$429.28 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $429.28 | 24 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Philips Electronics North America Corporation | $102.88 | 5 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $69.23 | 3 | $0 (2018) |
| Electromed, Inc. | $64.12 | 5 | $0 (2018) |
| GlaxoSmithKline, LLC. | $39.77 | 3 | $0 (2018) |
| JAZZ PHARMACEUTICALS INC. | $32.03 | 2 | $0 (2024) |
| Respiratory Technologies, Inc. | $25.00 | 1 | $0 (2017) |
| Grifols USA, LLC | $21.24 | 1 | $0 (2017) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $20.83 | 1 | $0 (2018) |
| Bayer HealthCare Pharmaceuticals Inc. | $19.37 | 1 | $0 (2019) |
| Allergan Inc. | $18.97 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $19.17 | 1 | JAZZ PHARMACEUTICALS INC. ($19.17) |
| 2020 | $14.06 | 1 | Philips Electronics North America Corporation ($14.06) |
| 2019 | $102.16 | 5 | Philips Electronics North America Corporation ($63.82) |
| 2018 | $148.76 | 10 | Electromed, Inc. ($49.21) |
| 2017 | $145.13 | 7 | AstraZeneca Pharmaceuticals LP ($56.37) |
All Payment Transactions
24 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/26/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $19.17 | General |
| Category: NEUROLOGY | ||||||
| 02/22/2020 | Philips Electronics North America Corporation | (8874) inCourage (Device) | Food and Beverage | Cash or cash equivalent | $14.06 | General |
| Category: Dental and Oral Health | ||||||
| 12/19/2019 | Allergan Inc. | TEFLARO (Drug) | Food and Beverage | In-kind items and services | $18.97 | General |
| Category: ANTI-INFECTIVE | ||||||
| 09/23/2019 | Philips Electronics North America Corporation | inCourage (Device) | Food and Beverage | Cash or cash equivalent | $15.38 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/22/2019 | Philips Electronics North America Corporation | inCourage (Device) | Food and Beverage | Cash or cash equivalent | $24.69 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/26/2019 | Bayer HealthCare Pharmaceuticals Inc. | Adempas (Drug) | Food and Beverage | In-kind items and services | $19.37 | General |
| Category: Cardio-pulmonary | ||||||
| 02/28/2019 | Philips Electronics North America Corporation | inCourage (Device) | Food and Beverage | Cash or cash equivalent | $23.75 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/06/2018 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $12.16 | General |
| Category: RESPIRATORY | ||||||
| 10/31/2018 | Jazz Pharmaceuticals Inc. | Xyrem (Drug) | Food and Beverage | In-kind items and services | $12.86 | General |
| Category: Neurology | ||||||
| 10/09/2018 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $15.66 | General |
| Category: HFCWO | ||||||
| 09/05/2018 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $4.11 | General |
| Category: HFCWO | ||||||
| 07/30/2018 | Sunovion Pharmaceuticals Inc. | LONHALA MAGNAIR (Drug) | Food and Beverage | In-kind items and services | $15.84 | General |
| Category: Respiratory | ||||||
| 06/05/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug), SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $20.83 | General |
| Category: RESPIRATORY | ||||||
| 03/13/2018 | Philips Electronics North America Corporation | Respiratoriy Care Undiv (Device) | Food and Beverage | Cash or cash equivalent | $25.00 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 02/20/2018 | AstraZeneca Pharmaceuticals LP | FASENRA (Drug) | Food and Beverage | In-kind items and services | $12.86 | General |
| Category: Respiratory | ||||||
| 01/12/2018 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $14.72 | General |
| Category: HFCWO | ||||||
| 01/12/2018 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $14.72 | General |
| Category: HFCWO | ||||||
| 11/06/2017 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $39.52 | General |
| Category: Respiratory | ||||||
| 10/05/2017 | GlaxoSmithKline, LLC. | BREO (Drug) | Food and Beverage | In-kind items and services | $14.59 | General |
| Category: RESPIRATORY | ||||||
| 08/08/2017 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $14.91 | General |
| Category: HFCWO | ||||||
| 07/06/2017 | Respiratory Technologies, Inc. | — | Food and Beverage | Cash or cash equivalent | $25.00 | General |
| Category: Airway Clearance Therapy | ||||||
| 05/03/2017 | AstraZeneca Pharmaceuticals LP | BEVESPI AEROSPHERE (Drug) | Food and Beverage | In-kind items and services | $16.85 | General |
| Category: Respiratory | ||||||
| 05/03/2017 | GlaxoSmithKline, LLC. | BREO (Drug) | Food and Beverage | In-kind items and services | $13.02 | General |
| Category: RESPIRATORY | ||||||
| 01/30/2017 | Grifols USA, LLC | Prolastin-C (Biological) | Food and Beverage | In-kind items and services | $21.24 | General |
| Category: Pulmonology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 113 | 194 | $86,857 | $23,396 |
| 2022 | 8 | 220 | 293 | $106,139 | $28,756 |
| 2021 | 10 | 384 | 494 | $142,424 | $37,098 |
| 2020 | 10 | 267 | 357 | $111,912 | $30,321 |
Total Patients
984
Total Services
1,338
Medicare Billing
$119,571
Procedure Codes
34
All Medicare Procedures & Services
34 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 40 | 65 | $29,018 | $8,535 | 29.4% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 17 | 41 | $29,594 | $6,669 | 22.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 18 | 18 | $10,266 | $3,169 | 30.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 13 | 37 | $7,348 | $2,356 | 32.1% |
| 99292 | Critical care, each additional 30 minutes | Facility | 2023 | 14 | 22 | $6,998 | $1,904 | 27.2% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 11 | 11 | $3,633 | $763.03 | 21.0% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 30 | 59 | $41,890 | $9,861 | 23.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 49 | 62 | $22,940 | $8,527 | 37.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 20 | 20 | $10,540 | $3,500 | 33.2% |
| 99292 | Critical care, each additional 30 minutes | Facility | 2022 | 19 | 37 | $11,618 | $3,268 | 28.1% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 23 | 36 | $9,540 | $2,977 | 31.2% |
| 94726 | Test to determine lung volumes using sensors | Facility | 2022 | 27 | 27 | $2,511 | $241.50 | 9.6% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2022 | 25 | 25 | $3,725 | $200.97 | 5.4% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2022 | 27 | 27 | $3,375 | $181.01 | 5.4% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 30 | 63 | $44,730 | $11,071 | 24.8% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 53 | 78 | $28,860 | $10,695 | 37.1% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 28 | 28 | $14,756 | $5,160 | 35.0% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 20 | 53 | $14,045 | $4,475 | 31.9% |
| 99292 | Critical care delivery critically ill or injured patient | Facility | 2021 | 21 | 33 | $10,362 | $2,920 | 28.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 14 | 14 | $3,850 | $930.10 | 24.2% |
| 94726 | Determination of lung volumes using plethysmography | Facility | 2021 | 65 | 65 | $6,000 | $574.15 | 9.6% |
| 94060 | Measurement and graphic recording of the amount and speed of breathed air, before and following medication administration | Facility | 2021 | 70 | 70 | $10,355 | $516.46 | 5.0% |
| 94729 | Measurement of lung diffusing capacity | Facility | 2021 | 70 | 70 | $8,686 | $449.89 | 5.2% |
| 99406 | Smoking and tobacco use intermediate counseling, greater than 3 minutes up to 10 minutes | Office | 2021 | 13 | 20 | $780.00 | $307.04 | 39.4% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 56 | 87 | $31,791 | $10,322 | 32.5% |
About Dr. Christopher Fraley, MD
Dr. Christopher Fraley, MD is a Pulmonary Disease healthcare provider based in Portland, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/25/2006. The National Provider Identifier (NPI) number assigned to this provider is 1821011693.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Fraley, MD has received a total of $429.28 in payments from pharmaceutical and medical device companies, with $19.17 received in 2024. These payments were reported across 24 transactions from 11 companies. The most common payment nature is "Food and Beverage" ($429.28).
As a Medicare-enrolled provider, Fraley has provided services to 984 Medicare beneficiaries, totaling 1,338 services with total Medicare billing of $119,571. Data is available for 4 years (2020–2023), covering 34 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Other Specialties Pulmonary Disease
- Location Portland, OR
- Active Since 07/25/2006
- Last Updated 06/26/2013
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1821011693
Products in Payments
- SMARTVEST (Device) $64.12
- inCourage (Device) $63.82
- SYMBICORT (Drug) $39.52
- BREO (Drug) $27.61
- Respiratoriy Care Undiv (Device) $25.00
- Prolastin-C (Biological) $21.24
- STIOLTO RESPIMAT (Drug) $20.83
- Adempas (Drug) $19.37
- XYWAV (Drug) $19.17
- TEFLARO (Drug) $18.97
- BEVESPI AEROSPHERE (Drug) $16.85
- LONHALA MAGNAIR (Drug) $15.84
- (8874) inCourage (Device) $14.06
- FASENRA (Drug) $12.86
- Xyrem (Drug) $12.86
- NUCALA (Biological) $12.16
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Portland
Jordan Fein, M.d, M.D
Pulmonary Disease — Payments: $69,409
Pulmonary Disease $69,409
Granthem Farr, Do, DO
Pulmonary Disease — Payments: $66,353
Pulmonary Disease $66,353
Melvin Morganroth, Md, MD
Pulmonary Disease — Payments: $23,131
Pulmonary Disease $23,131
Dr. Bishoy Zakhary, Md, MD
Pulmonary Disease — Payments: $10,967
Pulmonary Disease $10,967
Rick Balestra, M.d, M.D
Pulmonary Disease — Payments: $9,856
Pulmonary Disease $9,856
Vikram Sahni, M.d, M.D
Pulmonary Disease — Payments: $4,784
Pulmonary Disease $4,784